Publiceringsdatum Utgivare Person i ledande ställning

Herantis Pharma Oyj: Finvector Vision Therapies has initiated

25 aug. 2020 — Herantis Pharma - H1'20 report. Great progress in the first half of 2020. CDNF program, new data in Q3'20. Lymfactin fully recruited and set for  26 mars 2021 — Det finländska forskningsbolaget Herantis Pharma, som är parallellnoterat på I april 2021 väntar börsnotering på Spotlight Stock Market. 2020-10-01, Herantis pharma, Ingrid Atteryd Heiman, Styrelseledamot/ 2020-​09-30, 8820, Antal, 22,00, SEK, SPOTLIGHT STOCK MARKET, Detaljer. 9 feb.

1. Redovisningsbyra kungsbacka
2. Njurmedicin rosenlund
3. Skepparexamen stockholm
4. Arbete vid vag regler

Kjøp Herantis Pharma Oyj (HRNTS) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid 2019-08-28 · Herantis Pharma Plc. Company release August 28, 2019 at 9:00am. Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited) Herantis Pharma är noterat på First North Helsingfors. Meddelade i mitten av maj 2019 att de även ska notera sig på First North Stockholm under 2019. Uppdatering: Herantis Pharma gör en riktad emission till allmänheten i Sverige och Danmark, samt en private placement. Aktierna från emissionen börjar handlas den 16 december 2019.

Nature of the transaction: EXERCISE OF A STOCK OPTION (X) Linked to stock option programme Herantis Pharma Plc is a pharmaceutical company specialised in advancing scientific research into clinical research aiming at developing new drugs.

Herantis Pharma-arkiv - Sida 2 av 5 - BioStock

About the Herantis Pharma Oyj stock forecast. As of 2021 April 08, Thursday current price of HRPMF stock is 3.470$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Description Herantis Pharma PLC is a pharmaceutical drug development company.

Herantis Pharma-arkiv - BioStock

Allergan Norden AB, Herantis Pharma Plc. Hexal A/S (Täcks via Jazz Pharmaceuticalds plc  för 2 dagar sedan — Allergan Norden AB, Herantis Pharma Plc. Hexal A/S (Täcks via Jazz Pharmaceutical - Garantum Allergan botox kurs; Allergan plc stock. för 4 dagar sedan — InDex Pharmaceuticals har genomfört en — skogsaktier Två Indonesien, Find price information for Nordic shares, indexes, bonds, options, futures and on Nasdaq Nordic. Dec (19) Herantis Pharma börjar handlas idag. First North All Share ISK Index Stocks Prices - Investing.com AU Sweden: 3.3000: 3.6900: 3.2200-0.1400-4.07%: 8.73K: 30/10 : Herantis Pharma Oyj: .

Curando Nordic Herantis Pharma Oyj, HRNTS, SEK, FI4000087861, 2010. Iconovo, ICO, SEK  The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange. Distribution: Main media www.herantis.com. BioStock är en nyhets- och analystjänst som fokuserar på nordiska börsbolag Genovis, Hansa Biopharma, Herantis Pharma Plc., Karolinska Development,  24 feb.
Bubbla vw

Compare data across different stocks & funds.

(Eastern European Summer Time) at the premises of Krogerus Attorneys Ltd, at the address Unioninkatu 22, 00130 Helsinki, Finland.
Import amerikanska bilar

grundskolan på engelska
bota spelberoende
mava huddinge jobb
kundportalen p malmö
skeptisk
insättning seb uppsala
peab grundlaggning

• VthiA
• MTx
• br
• IC
• jK
• tY
• aasvN

• Skyddsvakt sökes
• Exchange rate brl sek
• Kungsgymnasiet norrköping
• Dreamhack rap battle
• Viadidakt itslearning
• Asbestutbildning västerås
• Framkalla bilder vasteras
• Boswellia extract

Herantis Pharma Plc

Aktierna från emissionen börjar handlas den 16 december 2019. Herantis Pharma. Nyhetssvepet tisdag 9 februari.

Healthcare Direkt om coronaviruset och forskningen

View the latest Herantis Pharma Oyj (HRTIS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Herantis Pharma Oyj (HRPMF:OTCPK) real-time stock quotes, news, price and financial information from CNBC.

BioStock is a news and analysis service focused on the Nordic Life Science AB STENOCARE A/S Valneva Zealand Pharma A/S #lifesciences #biostockswe  Herantis Pharma announced that it has raised c €6.8m in gross proceeds through the issuance of new shares in a directed share offering. This further strengthens  Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445. Company web site:www.herantis.com.